Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZMIZ1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | SLC33A1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | MDN1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | NQO1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | OR1Q1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | HMGN2 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
mRNA | RP11-2C24.9 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
mRNA | CDK5R2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | LONRF2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | IPO9 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |